[O2-4] SARS2-4

[O2-4-9] Determinants of the magnitude and breadth of SARS-CoV-2 neutralization after breakthrough infection.

*Sho Miyamoto¹, Takeshi Arashiro², Akira Ueno¹, Takayuki Kanno¹, Shinji Saito¹, Harutaka Katano¹, Shun Iida¹, Akira Ainai¹, Seiya Ozono¹, Takuya Hemmi¹, Yuichiro Hirata¹, Saya Moriyama³, Ryutaro Kotaki³, Hitomi Kinoshita⁴, Souichi Yamada⁴, Shuetsu Fukushi⁴, Yoshimasa Takahashi³, Tadaki Suzuki¹ (1. Department of Pathology, National Institute of Infectious Diseases, 2. Center for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, 3. Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, 4. Department of Virology I, National Institute of Infectious Diseases)